Southeast Clinical Oncology Research Consortium, Inc. (SCOR)

描述（由申请人提供）：SCCC-上州是两个成功的传统CCOP合并称为东南癌症控制联盟，公司。（SCCC）和Upstate卡罗莱纳（以下简称联盟）由23个组件和63个子组件组成，位于美国东南部的五个州（GA、NC、SC、TN和VA），非临床行政办公室（AO）位于温斯顿-塞勒姆，NC。该财团通过向东南部农村地区提供服务消除了一个关键障碍。AO提供专业知识，监管支持，培训，教育和主要研究者，使小型农村社区医院，私人诊所和独立执业者能够为患者提供临床试验。通过这种结构，农村中心将能够将学术产生的概念转化为真实的世界。经济上的限制使大多数医院和私人诊所无法分配所需的资源来独立进行研究。过去30年来，这一结构在支持农村社区方面取得了成功。这是医学博士Charles L Spurr的愿景，由阿特金斯和比尔登博士进行，以使临床试验在患者的家庭社区可用。 每个组成部分都有一名负责的研究者和协调员，以组织和促进临床研究参与。超过232名研究人员和140名研究人员分布在86个治疗中心，在各种社区环境中参与研究。广阔的地理区域增加了增加NCI申办的临床试验的机会。长期目标是：1）提供尖端的临床试验; 2）实施计划，以加强癌症护理提供; 3）建立现有的关系，并建立新的合作;和4）积极招募参与者的临床试验。各组成部分的集水区面积超过950万，人口结构多样化，包括大量非裔美国人。国家癌症研究所对这项赠款的支持将使有限的联邦资金在广大的农村地区得到最大限度的利用，帮助农村和医疗服务不足的人口。

DESCRIPTION (provided by applicant): The SCCC-Upstate is a merger of two successful legacy CCOPs known as Southeast Cancer Control Consortium, Inc. (SCCC) and Upstate Carolina (hereafter the Consortium) comprised of 23 components and 63 sub-components, located in a five-state area of the Southeast US (GA, NC, SC, TN, and VA) with a nonclinical Administrative Office (AO) in Winston-Salem, NC. The Consortium eliminates a critical barrier by supplying service to the rural southeastern area. The AO provides expertise, regulatory support, training, education, and principal investigators to enable small rural community hospitals, private practices, and solo practitioners the ability to provide clinical trials to ther patients. With this structure, rural centers will be able to translate academic-generated concepts to the real world. Economic constraints prohibit most hospitals and private practices from allocating the required resources to conduct research independently. This structure has been successful in supporting rural communities for the past 30 years. This was the vision of Charles L Spurr, MD that has been carried on by Drs. Atkins and Bearden to make clinical trials available in the patient's home community. Each component has a responsible investigator and coordinator to organize and promote clinical research participation. Over 232 investigators and 140 research staff located at 86 treatment centers are involved in the delivery of research in a variety of community settings. The vast geographical area improves the opportunity to increase access of NCI-sponsored clinical trials. The long-term objectives are to: 1) provide cutting edge clinical trials; 2) implement programs to enhance cancer care delivery; 3) build on existing relationships and establish new collaborations; and 4) actively enroll participants to clinical trials. The catchment area of the components is over 9.5 million, with diverse demographics including a significant African American population. NCI support of this grant will allow restricted federal dollars to be maximized over a vast rural geographic area reaching rural and medically underserved populations.